![Thomas Fuchs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Fuchs
Chief Tech/Sci/R&D Officer at
ELI LILLY AND COMPANY
Net worth: 97 192 $ as of 31/08/2026
Profile
Thomas Fuchs is currently an Independent Director at GeneDx Holdings Corp.
since 2025.
Dr. Fuchs is also the Chief Artificial Intelligence Officer & Senior VP at Eli Lilly & Co. since 2024.
Dr. Fuchs holds a doctorate from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/09/2026 | 1,146 ( 0% ) | 97 192 $ | 31/08/2026 |
Thomas Fuchs active positions
| Companies | Position | Start |
|---|---|---|
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 21/10/2024 |
| GENEDX HOLDINGS CORP. | Director/Board Member | 17/09/2025 |
Training of Thomas Fuchs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graz University of Technology
 Graz University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx Holdings Corp.
 GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
- Stock Market
- Insiders
- Thomas Fuchs
